InvestorsHub Logo
Followers 4
Posts 793
Boards Moderated 0
Alias Born 11/30/2006

Re: None

Monday, 08/29/2016 1:21:32 PM

Monday, August 29, 2016 1:21:32 PM

Post# of 4817
Everybody thought Teva was such a great partner for ATRS but everything I see has shown incompetence. Failed buyout, lack of leadership, missing on FDA approvals, allowing Epi generics before their's was release. I read on another site that Mylan has made storage, travel containers, school storage units and such that will only fit their pens, helping them secure much more of the generic market and they got an 18 month head start on it's competitors. Nice job, and release date still projected late 2017 or 2018. Stupid is, as stupid does. Profit still way out there for ATRS.